(565e) Identification of Key/Non-Key Process and Model Parameters of Polishing Chromatography, Primary Containers and Autoinjectors Using Mechanistic Models
AIChE Annual Meeting
2017
2017 Annual Meeting
Pharmaceutical Discovery, Development and Manufacturing Forum
PAT for Process Understanding, Reduced Testing, and Elucidation of Fundamental Phenomena in Drug Product/Substance Development
Wednesday, November 1, 2017 - 1:55pm to 2:15pm
Identifying key/non-key process parameters is an essential step in the Quality-by-Design methodology. It demonstrates true process understanding and it enables risk-based decision making. Typically, this is done by FMEA and DOE studies which have some important limitations. First-principles and mechanistic models are being used to advance the vision of rational drug substance development via a rigorous and quantitative Quality-by-Design approach. In this work, we use three mechanistic models to study the factor/response of drug/process/device systems of practical interest to industry. We employ well-established global sensitivity analysis techniques (Sobol indices) to address the so-called factor screening, factor prioritization and factor fixing setting [Saltelli et al., 2008]. This enables a rigorous analysis of key/non-key process and model parameters to accelerate design iterations, manage/reduce risk, and ultimately assure quality via a probabilistic in-silico QbD design space. This new methodology can work as a complement (or a replacement) of more traditional and experiential-based FMEA approaches. This is the first time such a rigorous analysis has been published for a polishing chromatography system. The application to the primary container case-study reveals that only half of the factors of this process are non-essential. For the autoinjector device two sub-components happen to be the most relevant to system variability.